Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP542221.RAve600b9aXH770LHMZJoT0n9QHv7sByjDQ5VdF1qZGMs130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP542221.RAve600b9aXH770LHMZJoT0n9QHv7sByjDQ5VdF1qZGMs130_assertion type Assertion NP542221.RAve600b9aXH770LHMZJoT0n9QHv7sByjDQ5VdF1qZGMs130_head.
- NP542221.RAve600b9aXH770LHMZJoT0n9QHv7sByjDQ5VdF1qZGMs130_assertion description "[This study aimed to investigate whether the susceptibility to CD in diabetic children is modified by positivity for HLA-DQB1*02-DQA1*05 and DQB1*0302-DQA1*03 and by alleles of single nucleotide polymorphisms within the genes encoding CTLA4, transforming growth factor (TGF)-beta, tumor necrosis factor (TNF)-alpha, interferon (IFN)-gamma, interleukin (IL)-1, IL-2, IL-6, and IL-10.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP542221.RAve600b9aXH770LHMZJoT0n9QHv7sByjDQ5VdF1qZGMs130_provenance.
- NP542221.RAve600b9aXH770LHMZJoT0n9QHv7sByjDQ5VdF1qZGMs130_assertion evidence source_evidence_literature NP542221.RAve600b9aXH770LHMZJoT0n9QHv7sByjDQ5VdF1qZGMs130_provenance.
- NP542221.RAve600b9aXH770LHMZJoT0n9QHv7sByjDQ5VdF1qZGMs130_assertion SIO_000772 16567828 NP542221.RAve600b9aXH770LHMZJoT0n9QHv7sByjDQ5VdF1qZGMs130_provenance.
- NP542221.RAve600b9aXH770LHMZJoT0n9QHv7sByjDQ5VdF1qZGMs130_assertion wasDerivedFrom befree-2016 NP542221.RAve600b9aXH770LHMZJoT0n9QHv7sByjDQ5VdF1qZGMs130_provenance.
- NP542221.RAve600b9aXH770LHMZJoT0n9QHv7sByjDQ5VdF1qZGMs130_assertion wasGeneratedBy ECO_0000203 NP542221.RAve600b9aXH770LHMZJoT0n9QHv7sByjDQ5VdF1qZGMs130_provenance.